More Sensitive Methods for Studying the Onset of Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$150,000
Active Dates
July 01, 2018 - June 30, 2020
Grant ID
G2018011
Acknowledgement
Goals
Glaucoma is a disease that causes the death of retinal cells that communicate with the brain. We have little knowledge of how this gradual process of cell death is influenced by other cells in the retina, and gaining insight into these mechanisms will allow us to develop new ways to treat glaucoma.
Summary
The goal of our research is to understand how glaucoma leads to adaptive changes in the retinal neurons that connect the eye with the brain, retinal ganglion cells (RGCs). In most cases of glaucoma, injury to RGCs occurs to their axons as they pass out of the eye. This optic nerve injury results in a progressive degeneration of RGCs, leading to blindness. Because glaucoma often goes undetected before a substantial number of RGCs have died, it is important to understand the early cellular events following injury. We aim to identify early changes in response to injury in an animal model of glaucoma.
Our first goal is to identify specific subsets of RGCs that will allow us to monitor the small electrical signatures of synaptic communication between retinal cells. Subsequently, we will monitor these electrical signals in the first week following injury to determine how retinal wiring and RGC function changes.
This proposal is unique in its approach to using patch-clamp electrophysiology and calcium imaging to understand the changes that occur in the fine dendritic process of RGCs, as well as the axon and cell body. We hope our research will lead to earlier diagnostic detection of glaucoma but more importantly, we aim to uncover retinal mechanisms that will allow us to slow or stop the progression of RGC degeneration following injury.
Grants
Related Grants
National Glaucoma Research
Understanding How Variants in LOXL1 Affect Pseudoexfoliation Glaucoma Risk
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Hannah Youngblood, PhD
Understanding How Variants in LOXL1 Affect Pseudoexfoliation Glaucoma Risk
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Hannah Youngblood, PhD
National Glaucoma Research
Defining the Role of a New Protein Target in Fluid Buildup in Glaucoma
Active Dates
July 01, 2023 - June 30, 2025
Principal Investigator
Rupalatha Maddala, PhD
Defining the Role of a New Protein Target in Fluid Buildup in Glaucoma
Active Dates
July 01, 2023 - June 30, 2025
Principal Investigator
Rupalatha Maddala, PhD
National Glaucoma Research
A Possible Connection Between Glaucoma and Alzheimer's Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Nick Marsh-Armstrong, PhD
A Possible Connection Between Glaucoma and Alzheimer's Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Nick Marsh-Armstrong, PhD